Intraocular penetration of Ara A and idu-therapeutic implications in clinical herpetic uveitis.
D000225:Adenine / Q000627:therapeutic use; D000818:Animals; D000963:Antimetabolites; D001082:Aqueous Humor; D001089:Arabinose / Q000627:therapeutic use; D002386:Cataract / Q000188:drug therapy; D002845:Chromatography; D003315:Cornea / Q000473:pathology / Q000601:surgery; D003857:Deoxyuridine / Q000627:therapeutic use*; D005128:Eye Diseases / Q000188:drug therapy / Q000601:surgery; D006801:Humans; D007042:Hypoxanthines / Q000627:therapeutic use; D007809:Lanolin / Q000627:therapeutic use; D008297:Male; D008899:Mineral Oil / Q000627:therapeutic use; D009705:Nucleosides / Q000627:therapeutic use*; D009824:Ointments / Q000627:therapeutic use; D010577:Petrolatum / Q000627:therapeutic use; D011817:Rabbits; D018139:Simplexvirus; D013997:Time Factors; D014605:Uveitis / Q000188:drug therapy* / Q000209:etiology
D000963:Antimetabolites; D007042:Hypoxanthines; D009705:Nucleosides; D009824:Ointments; D007809:Lanolin; D010577:Petrolatum; D008899:Mineral Oil; D001089:Arabinose; D000225:Adenine; D003857:Deoxyuridine